Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -26.517% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) N#Cc1nc(-c2ccccc2F)oc1NCc1ccccc1
b.) O=S(=O)(c1ccc(N2CCCC2c2nc3ccccc3s2)nc1)N1CCOCC1
Answer: b. O=S(=O)(c1ccc(N2CCCC2c2nc3ccccc3s2)nc1)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=S(=O)(c1ccc(N2CCCC2c2nc3ccccc3s2)nc1)N1CCOCC1
O=S(=O)(c1ccc(N2CCCC2c2nc3ccccc3s2)nc1)N1CCOCC1
4-[6-[2-(1,3-benzothiazol-2-yl)pyrrolidin-1-yl]pyridin-3-yl]sulfonylmorpholine